F605 in Louisiana. Pick another state for the same tag.
Against expectation — 2025
Louisiana cites F605 more often than its own record predicts
Versus expected share1.47×
1.47 times the share F605 takes of citations nationally.
Share of Louisiana citations1.04%
Of every deficiency written in Louisiana in 2025, this is the portion that was F605.
Louisiana1.04%
National0.70%
Share of all citations that were F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Louisiana surveyors wrote
F605 findings written in Louisiana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 12, 2026
Based on interview and record review, the facility failed to ensure a resident's drug regimen was free of chemical restraints and unnecessary medications for 1 (Resident #2) of 3 (Resident #1, Resident #2, and Resident #3) sampled residents. The facility failed to ensure:1. A resident receiving a psychotropic medication had an adequate indication for use; and2. Monitoring of a psychotropic medication for side effects and effectiveness was in place. Review of facility policy with a review date of 01/2026, titled Use Psychotropic Medications, revealed in part. 2. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction